Actively Recruiting
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Led by University of Helsinki · Updated on 2023-11-07
500
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
Sponsors
U
University of Helsinki
Lead Sponsor
H
Helsinki University Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.
CONDITIONS
Official Title
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with ovarian cancer
- Available tumor tissue/blood samples
You will not qualify if you...
- Inability to consent to the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Helsinki University and Helsinki University Hospital
Helsinki, Finland, 00014
Actively Recruiting
Research Team
A
Anniina Färkkilä, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here